| New Haven Foot Surgeons | |
|
32 Cherry St, Milford, CT 06460-3429 | |
| (203) 874-6755 | |
| (203) 877-7849 |
| Full Name | New Haven Foot Surgeons |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 32 Cherry St, Milford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437347754 | NPI | - | NPPES |
| 0706090003 | Other | CT | MEDICARE DMERC |
| C13287 | Other | CT | RAILROAD MEDICARE PIN |
| C13281 | Other | CT | RAILROAD MEDICARE PIN |
| CB1640 | Other | CT | RAILROAD MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Secondary |
| Provider Name | David C Novicki |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1093789349 PECOS PAC ID: 7416050075 Enrollment ID: I20070320000303 |
News Archive
People with bipolar I disorder tend to be aware of the potential for goal achievement to trigger mania and as a result dampen their emotions and avoid reward, preliminary research suggests.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
Insurance executives say they were caught off guard by the White House decision to allow them to revive canceled policies and many are worried about how to make it work.
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 3 days ago
| Provider Name | Jesse P Parks |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1578738621 PECOS PAC ID: 1254491061 Enrollment ID: I20081125000016 |
News Archive
People with bipolar I disorder tend to be aware of the potential for goal achievement to trigger mania and as a result dampen their emotions and avoid reward, preliminary research suggests.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
Insurance executives say they were caught off guard by the White House decision to allow them to revive canceled policies and many are worried about how to make it work.
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 3 days ago
| Provider Name | Marisa Kim Dematteo-santa |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1184809253 PECOS PAC ID: 6709935869 Enrollment ID: I20110727000198 |
News Archive
People with bipolar I disorder tend to be aware of the potential for goal achievement to trigger mania and as a result dampen their emotions and avoid reward, preliminary research suggests.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
Insurance executives say they were caught off guard by the White House decision to allow them to revive canceled policies and many are worried about how to make it work.
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 3 days ago
| Provider Name | Vsevolod Grinberg |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1881255917 PECOS PAC ID: 7810320256 Enrollment ID: I20220617000421 |
News Archive
People with bipolar I disorder tend to be aware of the potential for goal achievement to trigger mania and as a result dampen their emotions and avoid reward, preliminary research suggests.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
Insurance executives say they were caught off guard by the White House decision to allow them to revive canceled policies and many are worried about how to make it work.
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| New Haven Foot Surgeons 32 Cherry St, Milford, CT 06460-3429 Ph: (203) 874-6755 | New Haven Foot Surgeons 32 Cherry St, Milford, CT 06460-3429 Ph: (203) 874-6755 |
News Archive
People with bipolar I disorder tend to be aware of the potential for goal achievement to trigger mania and as a result dampen their emotions and avoid reward, preliminary research suggests.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
Insurance executives say they were caught off guard by the White House decision to allow them to revive canceled policies and many are worried about how to make it work.
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 3 days ago
Sanjay Patel, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 309 Seaside Ave, Suite 202, Milford, CT 06460 Phone: 203-876-7736 | |
David C Novicki, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 32 Cherry St, Milford, CT 06460 Phone: 203-874-6755 Fax: 203-877-7849 | |
Complete Foot Care Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 140 Clark St, Milford, CT 06460 Phone: 203-877-6501 Fax: 203-876-1296 | |
Ian J Richter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 309 Seaside Ave Ste 202, Milford, CT 06460 Phone: 203-876-7736 | |
Dr. Nili T Harpaz, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 309 Seaside Ave, Milford, CT 06460 Phone: 203-876-7736 | |
Milford Footcare Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 990 Bridgeport Avenue, Milford, CT 06460 Phone: 203-878-2642 Fax: 203-877-0849 | |
Dr. Karen A Borsos-debs, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 990 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-2642 Fax: 203-877-0849 |